Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹16 Cr₹13 Cr₹9.65 Cr₹6.17 Cr₹5.39 Cr

What is the latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS is ₹16 Cr based on Mar2025 Standalone results.
Year Total Non-Current Liabilities
Mar2025₹16 Cr
Mar2024₹13 Cr
Mar2023₹9.65 Cr
Mar2022₹6.17 Cr
Mar2021₹5.39 Cr

How is Total Non-Current Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹16 Cr
28.69
Mar2024 ₹13 Cr
32.20
Mar2023 ₹9.65 Cr
56.49
Mar2022 ₹6.17 Cr
14.52
Mar2021 ₹5.39 Cr -

Compare Total Non-Current Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹502.1 Cr -7.7% 18.5% 192.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,593.0 Cr 2% 6.7% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,737.0 Cr 3.5% 2.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,290.0 Cr 4.6% 9.9% 41.5% Stock Analytics
CIPLA ₹117,327.0 Cr -0.3% 3.7% -2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,994.0 Cr 1.1% 5.9% 6.6% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-7.7%

18.5%

192.1%

SENSEX

2.2%

5.1%

-7%


You may also like the below Video Courses